JCHOR

The Journal of Current Hematology & Oncology Research regularly publishes internationally qualified research in hematology and oncology within the current scholarly knowledge. This journal is indexed by indices that are considered international scientific journal indices (DRJI, ESJI, OAJI, etc.). According to the current Associate Professorship criteria, it is within the scope of International Article 1-d. Each article published in this journal corresponds to 5 points.

EndNote Style
ViewAll

Cover and Contents

Full Issue

: 247 : 138

Citation : Ünal S, Yağcı AM. The investigation of janus kinase 2 and calreticulin mutations in patients with essential thrombocytosis. J Curr Hematol Oncol Res. 2024;2(3):54-58.

Original Article - Hematology

Causes of acquired isolated neutropenia in adulthood: a single center study

: 300 : 171

Citation : Keklik M, Mert Yüce M, Akyol G, Mandacı Şanlı N, Çelik S, Eser B. Causes of acquired isolated neutropenia in adulthood: a single center study.J Curr Hematol Oncol Res. 2024;2(3):59-62.

Original Article - Hematology

: 349 : 159

Citation : Akyol G, Keklik M, Kaynar L, Ünal A. Follow-up of patients given isoniazid prophylaxis in multiple myeloma patients underwent autologous stem cell transplantation. J Curr Hematol Oncol Res. 2024;2(3):63-66.

Original Article - Hematology

The role of therapeutic plasma exchange in the treatment of patients with septic shock- single center experience

: 455 : 117

Citation : Çelik S, Erkurt MA, Sarıcı A. The role of therapeutic plasma exchange in the treatment of patients with septic shock- single center experience. J Curr Hematol Oncol Res. 2024;2(3):67-71.

Review - Hematology

: 420 : 141

Citation : Tan T, Ağırbaşlı M. Current status and potential future of PAI-1 inhibitors. J Curr Hematol Oncol Res. 2024;2(3): 72-75.

: 198 : 145

Citation : Aksöz Z. A case report of relapsed/refractory primary central nervous system lymphoma. J Curr Hematol Oncol Res. 2024; 2(3):76-78.
_Footer